706
Views
1
CrossRef citations to date
0
Altmetric
Research Article

HIV-1 genotyping tropism profile in an HIV-positive population throughout the Russian Federation

ORCID Icon, , , , , , , , , , , , , , , , , , , , , , ORCID Icon, , , , ORCID Icon, , , , , & | (Reviewing Editor) show all
Article: 1311470 | Received 28 Oct 2016, Accepted 23 Mar 2017, Published online: 13 Apr 2017

References

  • Adults PoAGf and Adolescents. (2009). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (pp. 1–161). Bethesda, MD: Department of Health and Human Services.
  • Ataher, Q., Portsmouth, S., Napolitano, L. A., Eng, S., Greenacre, A., Kambugu, A., … Tressler, R. (2012). The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa. Journal of the International AIDS Society, 15, 1–9.10.1186/1758-2652-15-2
  • Berger, E. A., Murphy, P. M., Farber, J. M. (1999). Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annual Review of Immunology, 17, 657–700.10.1146/annurev.immunol.17.1.657
  • Bobkova, M. (2013). Current status of HIV-1 diversity and drug resistance monitoring in the former USSR. AIDS Reviews, 15, 204–212.
  • Brumme, Z. L., Goodrich, J., Mayer, H. B., Brumme, C. J., Henrick, B. M., Wynhoven, B., … Harrigan, P. R. (2005). Molecular and clinical epidemiology of CXCR4‐using HIV‐1 in a large population of antiretroviral‐naive individuals. The Journal of Infectious Diseases, 192, 466–474.10.1086/jid.2005.192.issue-3
  • Dauwe, K., Mortier, V., Schauvliege, M., Van Den Heuvel, A., Fransen, K., Servais, J. Y., … Verhofstede, C. (2015). Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate. BMC Infectious Diseases, 15, 1–524.
  • Fabeni, L., Berno, G., Svicher, V., Ceccherini-Silberstein, F., Gori, C., Bertoli, A., … Pinnetti, C. (2015). Genotypic tropism testing in HIV-1 proviral DNA can provide useful information at low-level viremia. Journal of Clinical Microbiology, 53, 2935–2941.10.1128/JCM.00893-15
  • Ferrer, P., Montecinos, L., Tello, M., Tordecilla, R., Rodríguez, C., Ferrés, M., … Afani, A. (2013). HIV-1 tropism: A comparison between RNA and proviral DNA in routine clinical samples from Chilean patients. Virology Journal, 10, 1.
  • Gonzalez-Serna, A., Leal, M., Genebat, M., Abad, M. A., Garcia-Perganeda, A., Ferrando-Martinez, S., & Ruiz-Mateos, E. (2010). TROCAI (tropism coreceptor assay information): A new phenotypic tropism test and its correlation with trofile enhanced sensitivity and genotypic approaches. Journal of Clinical Microbiology, 48, 4453–4458.10.1128/JCM.00953-10
  • Kravchenko, A. (2012). Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens. Terapevticheskii arkhiv, 85, 125–129.
  • Levy, J. A. (1993). HIV pathogenesis and long-term survival. AIDS, 7, 1401–1410.10.1097/00002030-199311000-00001
  • Lopatukhin, A., Kireev, D., Kuevda, D., Shipulin, G., Luebke, N., & Kaiser, R. (2012, March 28–30), Validation of genotypic HIV-1 coreceptor tropism determination method in Russia and results comparison of two diverse labs. Abstracts in Reviews in Antiviral Therapy & Infectious Diseases, V.2:2012, Abstract P_62, p. 78. In 10th European Meeting on HIV & Hepatitis, Barcelona.
  • Lopatukhin, A, Kireev, D, Poliakov, A, Bukin, E. K., Kaiser, R., Luebke, N., … Shipulin, G. A. (2013). Klinicheskaia laboratornaia diagnostika [The first experience of application of standardized genotype technique of identification of HIV-tropism]. 46–48.
  • McGovern, R. A., Thielen, A., Mo, T., Dong, W., Woods, C. K., Chapman, D., … Harrigan, P. R. (2010). Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies. AIDS, 24, 2517–2525.10.1097/QAD.0b013e32833e6cfb
  • Meini, G., Rossetti, B., Bianco, C., Ceccherini-Silberstein, F., Di Giambenedetto, S., Sighinolfi, L., … Zazzi, M. (2014). Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy. Journal of Antimicrobial Chemotherapy, 69, 735–741.10.1093/jac/dkt426
  • Mulinge, M., Lemaire, M., Servais, J.-Y., Rybicki, A., Struck, D., da Silva, E. S., … Bercoff, D. P. (2013). HIV-1 tropism determination using a phenotypic env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRRF01_AE and CRF02_AG. PLoS ONE, 8, e60566.10.1371/journal.pone.0060566
  • Neogi, U., Prarthana, S. B., D’Souza, G., DeCosta, A., Kuttiatt, V. S., Ranga, U., & Shet, A. (2010). Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India. AIDS Research and Therapy, 7, 24.10.1186/1742-6405-7-24
  • Pokrovskaya, A. V., Kozyrina, N. V., Guschina, U. S., Yurin, O. G., Suvorova, Z. K., & Pokrovsky V. V. (2015, October 21–24). Portrait of the Patient study group. Lost opportunities for early ART. 15th European AIDS Conference, Barcelona.
  • Poveda, E., Paredes, R., Moreno, S., Alcamí, J., Córdoba, J., Delgado, R., … Pulido, F. (2012). Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists. AIDS Reviews, 14, 208–217.
  • Prosperi, M. C., Bracciale, L., Fabbiani, M., Di Giambenedetto, S., Razzolini, F., Meini, G., … De Luca, A. (2010). Research Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.
  • Seclen, E., Garrido, C., Gonzalez, M. D. M., González-Lahoz, J., de Mendoza, C., Soriano, V., & Poveda, E. (2010). High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists. Journal of Antimicrobial Chemotherapy, 65, 1486–1492.10.1093/jac/dkq137
  • Svicher, V., Alteri, C., Montano, M., D'Arrigo, R., Andreoni, M., Angarano, G., … Baldanti, F. (2012). Performance of genotypic tropism testing on proviral DNA in clinical practice: Results from the DIVA study group. New Microbiologica, 35, 17–25.
  • Svicher, V., D’Arrigo, R., Alteri, C., Andreoni, M., Angarano, G., Antinori, A., … Borderi, M. (2010). Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: Results from the OSCAR Study Group. New Microbiologica, 33, 195–206.
  • Symons, J., Vandekerckhove, L., Paredes, R., Verhofstede, C., Bellido, R., Demecheleer, E., … Nijhuis, M. (2012). Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice. Clinical Microbiology and Infection, 18, 606–612.10.1111/j.1469-0691.2011.03631.x
  • Thomson, M. M., de Parga, E. V., Vinogradova, A., Sierra, M., Yakovlev, A., Rakhmanova, A., … Vega, Y. (2007). New Insights into the origin of the HIV type 1 subtype a epidemic in former soviet union's countries derived from sequence analyses of preepidemically transmitted viruses. AIDS Research and Human Retroviruses, 23, 1599–1604.10.1089/aid.2007.0166
  • Vandekerckhove, L., Wensing, A., Kaiser, R., Brun-Vezinet, F., Clotet, B., De Luca, A., … Korn, K. (2011). European guidelines on the clinical management of HIV-1 tropism testing. The Lancet Infectious Diseases, 11, 394–407.10.1016/S1473-3099(10)70319-4
  • Vasil’ev A., Kazennova E., & Bobkova M. (2010). Analysis of the prevalence of CCR5 coreceptor antagonist resistance mutations among HIV-1 variants in Russia. Voprosy virusologii, 56, 32–37.